ALHC Quote, Financials, Valuation and Earnings

Centene has a net margin of -0.98% compared to Alignment Healthcare's net margin of 2.81%. Alignment Healthcare's return on equity of -77.81% beat Centene's return on equity of 12.65%.

Alignment Healthcare has a consensus price target of $18.22, signalling upside risk potential of 25.84%. On the other hand Centene has an analysts' consensus of $78.09 which suggests that it could grow by 38.44%. Given that Centene has higher upside potential than Alignment Healthcare, analysts believe Centene is more attractive than Alignment Healthcare.

Alignment Healthcare has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Centene has a beta of 0.478, suggesting its less volatile than the S&P 500 by 52.18%.

Alignment Healthcare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Centene offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Alignment Healthcare pays -- of its earnings as a dividend. Centene pays out -- of its earnings as a dividend.

Alignment Healthcare quarterly revenues are $926.9M, which are smaller than Centene quarterly revenues of $46.6B. Alignment Healthcare's net income of -$9.1M is lower than Centene's net income of $1.3B. Notably, Alignment Healthcare's price-to-earnings ratio is -- while Centene's PE ratio is 8.41x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Alignment Healthcare is 0.93x versus 0.17x for Centene. Usually stocks with elevated PS ratios are considered overvalued.

Molina Healthcare has a net margin of -0.98% compared to Alignment Healthcare's net margin of 2.67%. Alignment Healthcare's return on equity of -77.81% beat Molina Healthcare's return on equity of 25.66%.

Alignment Healthcare has a consensus price target of $18.22, signalling upside risk potential of 25.84%. On the other hand Molina Healthcare has an analysts' consensus of $360.24 which suggests that it could grow by 18.02%. Given that Alignment Healthcare has higher upside potential than Molina Healthcare, analysts believe Alignment Healthcare is more attractive than Molina Healthcare.

Alignment Healthcare has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Molina Healthcare has a beta of 0.633, suggesting its less volatile than the S&P 500 by 36.702%.

Alignment Healthcare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Molina Healthcare offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Alignment Healthcare pays -- of its earnings as a dividend. Molina Healthcare pays out -- of its earnings as a dividend.

Alignment Healthcare quarterly revenues are $926.9M, which are smaller than Molina Healthcare quarterly revenues of $11.1B. Alignment Healthcare's net income of -$9.1M is lower than Molina Healthcare's net income of $298M. Notably, Alignment Healthcare's price-to-earnings ratio is -- while Molina Healthcare's PE ratio is 14.74x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Alignment Healthcare is 0.93x versus 0.41x for Molina Healthcare. Usually stocks with elevated PS ratios are considered overvalued.

Progyny has a net margin of -0.98% compared to Alignment Healthcare's net margin of 4.65%. Alignment Healthcare's return on equity of -77.81% beat Progyny's return on equity of 11.16%.

Alignment Healthcare has a consensus price target of $18.22, signalling upside risk potential of 25.84%. On the other hand Progyny has an analysts' consensus of $26.25 which suggests that it could grow by 27.92%. Given that Progyny has higher upside potential than Alignment Healthcare, analysts believe Progyny is more attractive than Alignment Healthcare.

Alignment Healthcare has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Progyny has a beta of 1.372, suggesting its more volatile than the S&P 500 by 37.195%.

Alignment Healthcare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Progyny offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Alignment Healthcare pays -- of its earnings as a dividend. Progyny pays out -- of its earnings as a dividend.

Alignment Healthcare quarterly revenues are $926.9M, which are larger than Progyny quarterly revenues of $324M. Alignment Healthcare's net income of -$9.1M is lower than Progyny's net income of $15.1M. Notably, Alignment Healthcare's price-to-earnings ratio is -- while Progyny's PE ratio is 36.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Alignment Healthcare is 0.93x versus 1.59x for Progyny. Usually stocks with elevated PS ratios are considered overvalued.

UnitedHealth Group has a net margin of -0.98% compared to Alignment Healthcare's net margin of 5.74%. Alignment Healthcare's return on equity of -77.81% beat UnitedHealth Group's return on equity of 21.74%.

Alignment Healthcare has a consensus price target of $18.22, signalling upside risk potential of 25.84%. On the other hand UnitedHealth Group has an analysts' consensus of $397.36 which suggests that it could grow by 34.44%. Given that UnitedHealth Group has higher upside potential than Alignment Healthcare, analysts believe UnitedHealth Group is more attractive than Alignment Healthcare.

Alignment Healthcare has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison UnitedHealth Group has a beta of 0.561, suggesting its less volatile than the S&P 500 by 43.865%.

Alignment Healthcare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. UnitedHealth Group offers a yield of 2.84% to investors and pays a quarterly dividend of $2.10 per share. Alignment Healthcare pays -- of its earnings as a dividend. UnitedHealth Group pays out 52.29% of its earnings as a dividend. UnitedHealth Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Alignment Healthcare quarterly revenues are $926.9M, which are smaller than UnitedHealth Group quarterly revenues of $109.6B. Alignment Healthcare's net income of -$9.1M is lower than UnitedHealth Group's net income of $6.3B. Notably, Alignment Healthcare's price-to-earnings ratio is -- while UnitedHealth Group's PE ratio is 12.38x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Alignment Healthcare is 0.93x versus 0.67x for UnitedHealth Group. Usually stocks with elevated PS ratios are considered overvalued.